NIH-funded research NIH-funded research

Understanding how certain proteins affect airway inflammation and treatment responses in allergic diseases

Official title: Patient-Oriented Research Mentorship and Training in Upper Airway Allergic and Inflammatory Diseases

Funded at Brigham and Women's Hospital · NIH-11001959 · Data updated 2026-11-12

This study is looking at how certain proteins in your body affect inflammation in your airways, especially if you have asthma or chronic sinus issues, to see how new treatments can help you feel better while keeping an eye on any side effects.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startDecember 19, 2023
Project endNovember 30, 2028
Funding year2025
Award (this year)$174,031
NIH project number5K24AI180296-02
Project IDNIH-11001959 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from chronic rhinosinusitis with nasal polyps, severe asthma, or aspirin-exacerbated respiratory disease.

Less likely to help

Patients with non-allergic airway diseases or those not affected by the specific cytokines being studied may not benefit from this research.

What this research studies

This research investigates the roles of specific cytokines (IL-4, IL-5, and IL-13) in airway inflammation, particularly in conditions like asthma and chronic rhinosinusitis with nasal polyps. By studying how these proteins function and how their inhibition affects patients, the research aims to uncover the cellular mechanisms behind treatment responses to new biologic drugs. Patients will be monitored for both therapeutic benefits and potential side effects, such as joint pain, to better understand the overall impact of these treatments on their health.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies for patients with allergic airway diseases, enhancing their quality of life.

How similar studies have gone: Previous research has shown promising results in targeting similar cytokines for treating allergic diseases, indicating a potential for success in this approach.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Laidlaw, Tanya Maria — Brigham and Women's Hospital
  • Study coordinator: Laidlaw, Tanya Maria

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.